[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100658789":3},{"organization":4,"outcomesModule":7,"designInfo":22,"detailedDescription":11,"studyPopulation":25,"armGroups":26,"interventions":11,"overallOfficials":11,"centralContacts":11,"locations":36,"responsibleParty":80,"collaborators":11,"id":84,"slug":85,"hasResults":86,"nctId":87,"briefTitle":88,"officialTitle":89,"acronym":11,"eligibilityCriteria":90,"healthyVolunteers":86,"sex":91,"minAge":92,"maxAge":11,"enrollmentInfo":93,"targetDuration":11,"studyType":96,"phases":11,"briefSummary":97,"conditions":98,"keywords":11,"overallStatus":39,"whyStopped":11,"lastUpdateSubmitDate":101,"lastUpdatePostDateStruct":102,"startDateStruct":105,"completionDateStruct":107,"leadSponsor":109,"locationsCount":110},{"fullName":5,"class":6},"Shanghai Zhongshan Hospital","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":11},[9],{"measure":10,"description":11,"timeFrame":12},"Mean number of biopsy cores required to achieve a definitive diagnosis in the adaptive biopsy group",null,"After 8 weeks of the enrollment process was completed",[14,16,18,20],{"measure":15,"description":11,"timeFrame":12},"Prostate cancer detection rate",{"measure":17,"description":11,"timeFrame":12},"Missed diagnosis rates in the adaptive biopsy group and the mpMRI-US fusion-targeted biopsy group",{"measure":19,"description":11,"timeFrame":12},"The time of biopsy",{"measure":21,"description":11,"timeFrame":12},"Complication rate",{"allocation":11,"interventionModel":11,"interventionModelDescription":11,"primaryPurpose":11,"observationalModel":23,"timePerspective":24,"maskingInfo":11},"COHORT","PROSPECTIVE","Patients who underwent prostate biopsy at three medical centers in Shanghai: Minhang Hospital, Fudan University; Xuhui Hospital, Fudan University and Shanghai Geriatric Medical Center",[27,30,33],{"label":28,"type":11,"description":29,"interventionNames":11},"Adaptive Biopsy Group","Adaptive dynamic biopsy is performed using an intelligent system integrating preoperative imaging data with real-time intraoperative metabolic feedback.",{"label":31,"type":11,"description":32,"interventionNames":11},"Systemic Biopsy Group","A 10-12-core systematic biopsy.",{"label":34,"type":11,"description":35,"interventionNames":11},"mpMRI Fusion Targeted Biopsy Group","mpMRI-US fusion-guided targeted prostate biopsy",[37,54,63,72],{"facility":38,"status":39,"city":40,"state":11,"zip":11,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Minhang Hospital, Fudan University","RECRUITING","Shanghai","China","CN",{"type":44,"coordinates":45},"Point",[46,47],121.45806,31.22222,{"lat":47,"lon":46},[50],{"name":38,"role":51,"phone":52,"phoneExt":11,"email":53},"CONTACT","+86 64923400","zsyhuangjq@163.com",{"facility":55,"status":39,"city":40,"state":11,"zip":11,"country":41,"countryCode":42,"cosmosGeoPoint":56,"geoPoint":58,"contacts":59},"Shanghai Geriatric Medical Center",{"type":44,"coordinates":57},[46,47],{"lat":47,"lon":46},[60],{"name":55,"role":51,"phone":61,"phoneExt":11,"email":62},"+86 51371990","zsurology@126.com",{"facility":64,"status":39,"city":40,"state":11,"zip":11,"country":41,"countryCode":42,"cosmosGeoPoint":65,"geoPoint":67,"contacts":68},"Xuhui Hospital, Fudan University",{"type":44,"coordinates":66},[46,47],{"lat":47,"lon":46},[69],{"name":64,"role":51,"phone":70,"phoneExt":11,"email":71},"+86 36682220","wang.hang@zs-hospital.sh.cn",{"facility":73,"status":39,"city":40,"state":11,"zip":11,"country":41,"countryCode":42,"cosmosGeoPoint":74,"geoPoint":76,"contacts":77},"Zhongshan Hospital, Fudan University",{"type":44,"coordinates":75},[46,47],{"lat":47,"lon":46},[78],{"name":73,"role":51,"phone":79,"phoneExt":11,"email":71},"+86 64041990",{"type":81,"investigatorFullName":82,"investigatorTitle":83,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Hang Wang","Professor","100658789","development-of-an-intraoperative-adaptive-biopsy-system-for-prostate-cancer-integrating-imaging-navigation-with-metabolic-feedback-for-dynamic-decision-making-100658789",false,"NCT07856017","Development of an Intraoperative Adaptive Biopsy System for Prostate Cancer: Integrating Imaging Navigation With Metabolic Feedback for Dynamic Decision-Making","An MRI-Based Diagnostic Model for Prostate Cancer Localization: An Exploratory Study Integrating Radiomics and the Metabolic Microenvironment","Inclusion Criteria:\n\n1. Age ≥55 years;\n2. Indication for prostate biopsy;\n3. Availability of total prostate-specific antigen (tPSA), free PSA (fPSA) levels, and multiparametric MRI (mpMRI) results within 1 month prior to biopsy.\n\nExclusion Criteria:\n\n1. Pathological diagnosis of malignancies other than prostatic acinar adenocarcinoma;\n2. Concomitant malignant tumors potentially affecting imaging findings (e.g., rectal, bladder, or testicular cancer);\n3. Cachexia or organ function decompensation.","MALE","55 Years",{"count":94,"type":95},90,"ESTIMATED","OBSERVATIONAL","Development of an Intelligent System Integrating Preoperative Imaging and Real-Time Intraoperative Metabolic Feedback to Dynamically Optimize Biopsy core Placement for Individualized Precision Sampling.",[99,100],"Prostate Cancer (Adenocarcinoma)","Prostate Cancer (Diagnosis)","2026-09-27",{"date":103,"type":104},"2026-10-02","ACTUAL",{"date":106,"type":104},"2026-07-21",{"date":108,"type":95},"2028-08-31",{"name":5,"class":6},4]